FDA Inspection
Blossom PharmaceuticalsBlossom Pharmaceuticals – FDA Inspection, Apr 11, 2025
Record Details
This FDA Inspection record concerns Blossom Pharmaceuticals, with an inspection on April 11, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 15f86524-6141-481d-b505-0f7ff617faee
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1273155
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blossom Pharmaceuticals
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Blossom Pharmaceuticals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.